安进 - 扩大其直接面向患者的计划Amgennow™,新增Aimovig(®) (Erenumab-Aooe)和Amjevita(®) (Adalimumab-Atto)

美股速递
Dec 20, 2025

安进 - 扩大其直接面向患者的计划Amgennow™,新增Aimovig(®) (Erenumab-Aooe)和Amjevita(®) (Adalimumab-Atto)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10